This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ribstein, J. Articles by Mimran, A. Search for Related Content PubMed PubMed Citation Articles by Ribstein, J. Articles by Mimran, A. Related Collections ACE/Angiotension receptors Other hypertension Other etiology

(Hypertension. 1999;33:90-95.)
© 1999 American Heart Association, Inc.

Scientific Contributions

Renal Characteristics and Effect of Angiotensin Suppression in Oral Contraceptive Users

Jean Ribstein; Jean-Michel Halimi; Guilhem du Cailar; Albert Mimran

From the Department of Medicine, Hôpital Lapeyronie, Montpellier, France.

Correspondence to Jean Ribstein, MD, Department of Medicine, Hôpital Lapeyronie, 34295 Montpellier, Cedex 5, France.

Abstract—The determinants of the increase in arterial blood pressure associated with the use of estrogen-progestogen oral contraceptives (OC) remain poorly known. The purpose of this study was to assess the renal characteristics and the role of the renin-angiotensin system in women with OC-associated hypertension. Urinary clearances of technetium-labeled diethylene triaminopentaacetic acid (glomerular filtration rate) and ¹³¹I-ortho iodohippurate (effective renal plasma flow) were estimated before and after acute administration of captopril in 38 women who became hypertensive while taking OC, 38 non-OC users with essential hypertension matched for age, body mass index, and level of blood pressure, and 38 normotensive women (19 with and 19 without OC). Plasma renin activity was higher in OC hypertensives when compared with those with essential hypertension, but captopril-induced changes in blood pressure and renal hemodynamics and function were similar in both groups. In addition, 24-hours urinary albumin excretion was increased in OC users when compared with nonusers with similar arterial blood pressure. In 13 hypertensive women followed up for 6 months after OC withdrawal, a decrease in plasma renin activity, blood pressure, and glomerular filtration rate but no significant change in urinary albumin excretion and captopril-induced changes in blood pressure and renal hemodynamics were observed. These results indicate that the use of OC is associated with an increased albuminuria and no evidence of a prominent role for the renin-angiotensin system in the maintenance of high blood pressure and renal hemodynamics when compared with non-OC users with essential hypertension.

Key Words: oral contraceptives • hypertension, essential • microalbuminuria • renal hemodynamics • angiotensin-converting enzyme inhibition

This article has been cited by other articles:

				A. L C. La Corte, A. M Carter, A. J Turner, P. J Grant, and N. M Hooper The bradykinin-degrading aminopeptidase P is increased in women taking the oral contraceptive pill Journal of Renin-Angiotensin-Aldosterone System, December 1, 2008; 9(4): 221 - 225. [Abstract] [PDF]

				L. L. Yanes, J. C. Sartori-Valinotti, and J. F. Reckelhoff Sex Steroids and Renal Disease: Lessons From Animal Studies Hypertension, April 1, 2008; 51(4): 976 - 981. [Full Text] [PDF]

				S. Basi, P. Fesler, A. Mimran, and J. B. Lewis Microalbuminuria in Type 2 Diabetes and Hypertension: A marker, treatment target, or innocent bystander? Diabetes Care, February 1, 2008; 31(Supplement_2): S194 - S201. [Full Text] [PDF]

				Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J., June 11, 2007; (2007) ehm236v1. [Full Text] [PDF]

				S. B. Ahmed, P. Hovind, H.-H. Parving, P. Rossing, D. A. Price, L. M. Laffel, M. C. Lansang, R. Stevanovic, N. D.L. Fisher, and N. K. Hollenberg Oral Contraceptives, Angiotensin-Dependent Renal Vasoconstriction, and Risk of Diabetic Nephropathy Diabetes Care, August 1, 2005; 28(8): 1988 - 1994. [Abstract] [Full Text] [PDF]

				J. C. Verhave, H. L. Hillege, J. G. M. Burgerhof, G. Navis, D. de Zeeuw, and P. E. de Jong Cardiovascular Risk Factors Are Differently Associated with Urinary Albumin Excretion in Men and Women J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1330 - 1335. [Abstract] [Full Text] [PDF]

				T. B. M. Monster, W. M. T. Janssen, P. E. de Jong, L. T. W. de Jong-van den Berg, and for the Prevention of Renal and Vascular End Stage Oral Contraceptive Use and Hormone Replacement Therapy Are Associated With Microalbuminuria Arch Intern Med, September 10, 2001; 161(16): 2000 - 2005. [Abstract] [Full Text] [PDF]

				A. K. Kang, J. A. Duncan, D. C. Cattran, J. S. Floras, V. Lai, J. W. Scholey, and J. A. Miller Effect of oral contraceptives on the renin angiotensin system and renal function Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R807 - R813. [Abstract] [Full Text] [PDF]